loading
Tectonic Therapeutic Inc stock is traded at $22.32, with a volume of 155.42K. It is up +0.18% in the last 24 hours and up +9.68% over the past month. Tectonic Therapeutic Inc is a biotechnology company focused on the discovery and development of therapeutic proteins and antibodies that modulate the activity of GPCRs. Its technology platform called GEODe, Tectonic is focused on developing biologic medicines that overcome the existing challenges of GPCR-targeted drug discovery to modify the course of disease. Company focus on areas of important unmet medical need, often where therapeutic options are poor or nonexistent, and where new medicines have the potential to improve patient quality of life or extend duration of life. Pipeline includes TX000045, Group 2 PH, TX2100: GPCR Antagonist for Hereditary Hemorrhagic Telangiectasia (HHT), Fibrosis.
See More
Previous Close:
$22.28
Open:
$22.38
24h Volume:
155.42K
Relative Volume:
0.77
Market Cap:
$416.77M
Revenue:
-
Net Income/Loss:
-
P/E Ratio:
-
EPS:
-
Net Cash Flow:
-
1W Performance:
+1.87%
1M Performance:
+9.68%
6M Performance:
-52.25%
1Y Performance:
+31.29%
1-Day Range:
Value
$22.09
$23.00
1-Week Range:
Value
$21.41
$23.61
52-Week Range:
Value
$13.70
$61.07

Tectonic Therapeutic Inc Stock (TECX) Company Profile

Name
Name
Tectonic Therapeutic Inc
Name
Phone
(339) 666-3320
Name
Address
490 ARSENAL WAY, WATERTOWN
Name
Employee
51
Name
Twitter
Name
Next Earnings Date
2024-11-07
Name
Latest SEC Filings
Name
TECX's Discussions on Twitter

Compare TECX with other stocks

Stocks Price Market Cap Revenue Net Income Cash Flow EPS
Biotechnology icon
TECX
Tectonic Therapeutic Inc
22.32 416.02M 0 0 0 0.00
Biotechnology icon
VRTX
Vertex Pharmaceuticals Inc
469.65 121.28B 11.10B -988.90M -1.26B -3.92
Biotechnology icon
REGN
Regeneron Pharmaceuticals Inc
563.10 60.96B 14.09B 4.50B 2.96B 39.28
Biotechnology icon
ALNY
Alnylam Pharmaceuticals Inc
328.81 42.77B 2.35B -269.70M -75.39M -2.09
Biotechnology icon
ARGX
Argen X Se Adr
591.99 36.21B 2.58B 1.06B -1.28B 16.33
Biotechnology icon
ONC
Beone Medicines Ltd Adr
291.47 32.08B 3.81B -644.79M -669.77M -6.24

Tectonic Therapeutic Inc Stock (TECX) Upgrades & Downgrades

Date Action Analyst Rating Change
Jul-21-25 Initiated Truist Buy
Jun-11-25 Resumed Raymond James Outperform
Apr-21-25 Initiated Mizuho Outperform
Nov-20-24 Initiated Raymond James Outperform
Aug-22-24 Initiated Wells Fargo Overweight
Jun-26-24 Initiated Piper Sandler Overweight
Jun-24-24 Initiated TD Cowen Buy
Dec-18-23 Downgrade Mizuho Buy → Neutral
Jan-05-22 Downgrade BTIG Research Buy → Neutral
Nov-19-21 Downgrade Morgan Stanley Overweight → Equal-Weight
Jun-15-21 Initiated BTIG Research Buy
May-27-21 Initiated Needham Buy
Mar-09-21 Initiated Barclays Overweight
Mar-02-21 Initiated Stifel Hold
Nov-11-20 Initiated Berenberg Buy
Mar-31-20 Downgrade H.C. Wainwright Buy → Neutral
Jun-27-19 Initiated Mizuho Buy
Apr-05-19 Initiated Janney Buy
Oct-10-18 Initiated Guggenheim Buy
Oct-02-18 Reiterated H.C. Wainwright Buy
Sep-17-18 Initiated H.C. Wainwright Buy
Jul-16-18 Initiated Wedbush Outperform
Jul-16-18 Initiated Wells Fargo Outperform
View All

Tectonic Therapeutic Inc Stock (TECX) Latest News

pulisher
10:58 AM

How does Tectonic Therapeutic Inc. compare to its industry peersBreakthrough stock performance - jammulinksnews.com

10:58 AM
pulisher
09:36 AM

Competitive Positioning of Tectonic Therapeutic Inc.: Is It Leading or LaggingHigh Win Rate Stock Ideas - Newser

09:36 AM
pulisher
08:54 AM

Is Tectonic Therapeutic Inc. stock overvalued or undervaluedAccelerated wealth expansion - jammulinksnews.com

08:54 AM
pulisher
08:52 AM

How Tectonic Therapeutic Inc. stock performs during market volatilityTop Momentum Stock Pick - Newser

08:52 AM
pulisher
08:02 AM

Is Tectonic Therapeutic Inc. Stock a Smart Buy in 2025 Investment Analysis InsideFast Gains With Reduced Risk - Newser

08:02 AM
pulisher
06:17 AM

What are analysts’ price targets for Tectonic Therapeutic Inc. in the next 12 monthsDiscover market opportunities others miss - jammulinksnews.com

06:17 AM
pulisher
05:14 AM

What institutions are buying Tectonic Therapeutic Inc. stock nowInvestor Friendly Risk Reward - Newser

05:14 AM
pulisher
Jul 26, 2025

What makes Tectonic Therapeutic Inc. stock price move sharplyHigh Return Intraday Picks - Metal.it

Jul 26, 2025
pulisher
Jul 26, 2025

Wall Street Zen Downgrades Tectonic Therapeutic (NASDAQ:TECX) to Sell - Defense World

Jul 26, 2025
pulisher
Jul 25, 2025

Tectonic Therapeutic Inc. Stock Analysis and ForecastPowerful profit generation - PrintWeekIndia

Jul 25, 2025
pulisher
Jul 25, 2025

What analysts say about Tectonic Therapeutic Inc. stock outlookPortfolio Boosting Stock Alerts - Newser

Jul 25, 2025
pulisher
Jul 25, 2025

Is Tectonic Therapeutic Inc. a good long term investmentMarket-crushing stock picks - PrintWeekIndia

Jul 25, 2025
pulisher
Jul 24, 2025

How high can Tectonic Therapeutic Inc. stock price go in 2025Breakthrough profits - jammulinksnews.com

Jul 24, 2025
pulisher
Jul 23, 2025

What analysts say about Tectonic Therapeutic Inc. stockExplosive trading growth - Autocar Professional

Jul 23, 2025
pulisher
Jul 22, 2025

What drives Tectonic Therapeutic Inc. stock priceExponential wealth increase - jammulinksnews.com

Jul 22, 2025
pulisher
Jul 22, 2025

Tectonic Therapeutic (NASDAQ:TECX) Now Covered by Truist Financial - Defense World

Jul 22, 2025
pulisher
Jul 21, 2025

Tectonic Therapeutic, Inc. Rings the Closing Bell - Nasdaq

Jul 21, 2025
pulisher
Jul 21, 2025

Truist Securities initiates Tectonic Therapeutics stock with Buy rating - Investing.com

Jul 21, 2025
pulisher
Jul 21, 2025

Truist Securities initiates Tectonic Therapeutics stock with Buy rating By Investing.com - Investing.com South Africa

Jul 21, 2025
pulisher
Jul 15, 2025

Why Tectonic Therapeutic Inc. stock attracts strong analyst attentionFree Deep Market Trend Analysis - Newser

Jul 15, 2025
pulisher
Jul 15, 2025

Russell 2000 Implied Analyst Target Price at $269.34, 20.67% Upside to Current Price of $223.21. - AInvest

Jul 15, 2025

Tectonic Therapeutic Inc Stock (TECX) Financials Data

There is no financial data for Tectonic Therapeutic Inc (TECX). Check out other stocks for more information.

Revenue

loading

Net Income

loading

Cash Flow

loading

EPS

loading

Tectonic Therapeutic Inc Stock (TECX) Insider Trading

Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total
SPRINGER TIMOTHY A
Director
Apr 10 '25
Buy
16.73
45,858
767,204
1,449,652
SPRINGER TIMOTHY A
Director
Apr 09 '25
Buy
14.76
21,071
311,020
1,403,794
SPRINGER TIMOTHY A
Director
Apr 11 '25
Buy
16.31
9,478
154,586
4,334,846
SPRINGER TIMOTHY A
Director
Apr 10 '25
Buy
16.73
8,092
135,379
4,325,368
SPRINGER TIMOTHY A
Director
Apr 09 '25
Buy
14.76
3,718
54,880
4,317,276
SPRINGER TIMOTHY A
Director
Apr 07 '25
Buy
17.10
412,500
7,053,750
1,382,723
SPRINGER TIMOTHY A
Director
Apr 07 '25
Buy
17.10
87,500
1,496,250
4,313,558
MCGUIRE TERRANCE
Director
Apr 07 '25
Sale
17.10
500,000
8,550,000
573,062
SPRINGER TIMOTHY A
Director
Feb 05 '25
Buy
50.00
660,000
33,000,000
970,223
SPRINGER TIMOTHY A
Director
Feb 05 '25
Buy
54.14
129,294
6,999,977
4,226,058
$23.40
price down icon 0.97%
$36.67
price up icon 0.22%
$103.95
price up icon 0.42%
$28.67
price up icon 3.99%
$115.31
price up icon 0.65%
biotechnology ONC
$291.47
price down icon 1.68%
Cap:     |  Volume (24h):